This is a StreetInsider.com Premium Only Page

(VIR) – StreetInsider.com Reports

Apr 18, 2024 08:48 AM Vir Biotechnology Inc. (VIR) Announces CFO Departure

Apr 18, 2024 08:02 AM Vir Biotechnology Inc. (VIR) Appoints Norbert Bischofberger and Ramy Farid to its Board

Feb 29, 2024 06:06 AM Vir Biotechnology (VIR) PT Lowered to $28 at Goldman Sachs

Feb 23, 2024 07:44 AM Vir Biotechnology (VIR) PT Raised to $10 at JPMorgan

Feb 22, 2024 04:08 PM Vir Biotechnology Inc. (VIR) Tops Q4 EPS by 22c, Beats on Revenue

Feb 20, 2024 04:30 PM Vir Biotechnology Inc. (VIR) Announces Resignation of Chief Medical Officer

Feb 14, 2024 06:36 AM Vir Biotechnology (VIR) PT Raised to $110 at H.C. Wainwright

Jan 29, 2024 02:31 AM JPMorgan Downgrades Vir Biotechnology (VIR) to Neutral

Jan 23, 2024 06:38 AM Vir Biotechnology (VIR) PT Lowered to $85 at H.C. Wainwright

Jan 4, 2024 04:17 PM Vir Biotechnology (VIR) PT Lowered to $22 at Leerink Partners

Dec 13, 2023 04:08 PM Vir Biotechnology (VIR) Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation

Nov 6, 2023 09:04 AM Vir Biotechnology (VIR) PT Lowered to $12 at Morgan Stanley

Nov 6, 2023 03:13 AM Vir Biotechnology (VIR) PT Lowered to $27 at Morgan Stanley

Nov 3, 2023 04:39 PM Vir Biotechnology Inc. (VIR) Files Mixed Shelf

Nov 3, 2023 07:30 AM Vir Biotechnology (VIR) PT Lowered to $15 at Needham & Company

Nov 2, 2023 04:35 PM Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 1c

Oct 30, 2023 08:02 AM Vir Biotechnology (VIR) Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer

Oct 3, 2023 07:59 AM Vir Biotechnology (VIR) Awarded BARDA Funding to Support Development of Antibody Platform Technologies for Global Infectious Disease Threats

Sep 20, 2023 06:06 AM Vir Biotechnology Inc. (VIR) Announces COO Departure

Sep 8, 2023 07:45 AM BofA Securities Downgrades Vir Biotechnology (VIR) to Neutral, 'Near-term data unlikely to lift sentiment'

Aug 7, 2023 06:39 AM Vir Biotechnology (VIR) PT Lowered to $95 at H.C. Wainwright

Aug 3, 2023 04:11 PM Vir Biotechnology Inc. (VIR) Misses Q2 EPS by 25c, misses on revenue

Jul 24, 2023 09:22 AM Vir Biotechnology (VIR) PT Lowered to $23 at BofA Securities

Jul 21, 2023 06:06 AM Vir Biotechnology (VIR) PT Lowered to $24 at JPMorgan

Jul 21, 2023 05:49 AM Vir Biotechnology (VIR) PT Lowered to $28 at Goldman Sachs

Jul 21, 2023 04:09 AM Vir Biotechnology (VIR) PT Lowered to $41 at Barclays

Jul 20, 2023 11:49 AM Vir Biotechnology (VIR) PT Lowered to $15 at Morgan Stanley

Jul 20, 2023 10:00 AM Increasing unusual option volume: VIR GOSS FNGR BMBL JETS TPX FYBR

Jul 20, 2023 08:05 AM Vir Biotechnology Inc. (VIR) to Resume Trading at 8:30 a.m. After Phase 2 Study Fails

Jul 20, 2023 08:00 AM Vir Biotechnology Inc. (VIR) Announces Topline Data from Phase 2 PENINSULA Trial of VIR-2482

Jul 20, 2023 07:55 AM Vir Biotechnology Inc. (VIR) Halted, News Pending

May 4, 2023 04:50 PM Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 19c

May 2, 2023 09:01 AM Vir Biotechnology (VIR) Receives $10M Grant to Develop T Cell Vaccine Platform

Mar 6, 2023 03:53 PM Today's most important upgrades

Mar 6, 2023 09:21 AM Vir Biotechnology (VIR) upgraded on 'attractive upside potential' from positive data

Mar 6, 2023 06:35 AM Vir Biotechnology (VIR) PT Lowered to $100 at H.C. Wainwright

Mar 6, 2023 06:32 AM JPMorgan Upgrades Vir Biotechnology (VIR) to Overweight, 'Underappreciated Link Between Phase 2 PENINSULA & Mainland Flu Prevention Market'

Feb 23, 2023 04:27 PM Vir Biotechnology Inc. (VIR) Misses Q4 EPS by 41c

Feb 23, 2023 06:15 AM Vir Biotechnology (VIR) PT Raised to $53 at Goldman Sachs

Feb 22, 2023 08:31 AM Vir Biotechnology (VIR) Reports Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence

Feb 21, 2023 03:55 PM Today's most important upgrades

Feb 21, 2023 10:12 AM Vir Biotechnology (VIR) risk/reward 'compelling' states Goldman Sachs

Feb 21, 2023 08:48 AM Walmart, Home Depot and Credit Suisse fall premarket; General Mills rises

Feb 21, 2023 03:05 AM Goldman Sachs Upgrades Vir Biotechnology (VIR) to Buy

Feb 16, 2023 08:32 AM Vir Biotechnology Inc. (VIR) Appoints Sung Lee as CFO

Feb 13, 2023 04:46 PM Vir Biotechnology Inc. (VIR) to continue advancing next-generation COVID-19 solutions independently or with other partners besides GSK

Jan 27, 2023 02:53 AM Morgan Stanley Upgrades Vir Biotechnology (VIR) to Equalweight

Jan 25, 2023 08:30 AM Vir Biotechnology Inc. (VIR) Announces CEO Retirement, Appoints Marianne De Backer as Successor

Dec 21, 2022 08:01 AM Vir Biotechnology Inc. (VIR) hits target enrollment in phase 2 trial of VIR-2482 in influenza A

Nov 7, 2022 05:39 AM Vir Biotechnology (VIR) Presents New Data for VIR-2218 and VIR-3434